Mucopolysaccharidosis Type II (MPS II )
Mucopolysaccharidosis Type II (MPS II) was added to the Recommended Uniform Screening Panel (RUSP) in August of 2022.
NewSTEPs partners with state newborn screening programs, partner organizations and federal agencies to provide a central location for MPS II resources. If you have additional resources that you would like included, please contact NewSTEPs.
Newborn Screening Status
NewSTEPs has compiled educational resources that can be used to support screening efforts in states and regions. For all educational resources, pertinent publications and archived webinars please visit the NewSTEPs resource library and filter for MPS II.
Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC) Recommendations
Chair Letter to Secretary
(March 15, 2022)
Secretary's Interim Response
(June 13, 2022)
For information shared during recent ACHDNC meetings relative to MPS II, please visit theACHDNC meeting webpage.